319 related articles for article (PubMed ID: 15505641)
1. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
Tiwari AK; Deshpande SN; Rao AR; Bhatia T; Mukit SR; Shriharsh V; Lerer B; Nimagaonkar VL; Thelma BK
Pharmacogenomics J; 2005; 5(1):60-9. PubMed ID: 15505641
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
Tiwari AK; Deshpande SN; Lerer B; Nimgaonkar VL; Thelma BK
Pharmacogenomics J; 2007 Oct; 7(5):305-11. PubMed ID: 16969362
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
4. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
5. Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia.
Tay JK; Tan CH; Chong SA; Tan EC
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1297-302. PubMed ID: 17611010
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
Basile VS; Ozdemir V; Masellis M; Meltzer HY; Lieberman JA; Potkin SG; Macciardi FM; Petronis A; Kennedy JL
Mol Psychiatry; 2001 Mar; 6(2):230-4. PubMed ID: 11317228
[TBL] [Abstract][Full Text] [Related]
7. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
9. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
[TBL] [Abstract][Full Text] [Related]
10. Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia.
Shinkai T; De Luca V; Hwang R; Matsumoto C; Hori H; Ohmori O; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Nakamura J; Kennedy JL
Neurosci Lett; 2005 Nov; 388(2):116-20. PubMed ID: 16039055
[TBL] [Abstract][Full Text] [Related]
11. No association between dopamine D4 receptor gene -521 C/T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Choi JE; Paik JW; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2007; 55(1):47-51. PubMed ID: 17556853
[TBL] [Abstract][Full Text] [Related]
12. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia.
Segman RH; Goltser T; Heresco-Levy U; Finkel B; Shalem R; Schlafman M; Yakir A; Greenberg D; Strous R; Lerner A; Shelevoy A; Lerer B
Pharmacogenomics J; 2003; 3(5):277-83. PubMed ID: 14583797
[TBL] [Abstract][Full Text] [Related]
13. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
Gałecki P; Pietras T; Szemraj J
Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
[TBL] [Abstract][Full Text] [Related]
14. Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia.
Inada T; Koga M; Ishiguro H; Horiuchi Y; Syu A; Yoshio T; Takahashi N; Ozaki N; Arinami T
Pharmacogenet Genomics; 2008 Apr; 18(4):317-23. PubMed ID: 18334916
[TBL] [Abstract][Full Text] [Related]
15. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia.
Kang SG; Lee HJ; Choi JE; An H; Rhee M; Kim L
Hum Psychopharmacol; 2009 Jan; 24(1):55-60. PubMed ID: 19051221
[TBL] [Abstract][Full Text] [Related]
16. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.
Basile VS; Ozdemir V; Masellis M; Walker ML; Meltzer HY; Lieberman JA; Potkin SG; Alva G; Kalow W; Macciardi FM; Kennedy JL
Mol Psychiatry; 2000 Jul; 5(4):410-7. PubMed ID: 10889552
[TBL] [Abstract][Full Text] [Related]
17. Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.
Thelma B; Srivastava V; Tiwari AK
Pharmacogenomics; 2008 Sep; 9(9):1285-306. PubMed ID: 18781856
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
19. No evidence for an association between G protein beta3 subunit gene C825T polymorphism and tardive dyskinesia in schizophrenia.
Lee HJ; Kang SG; Paik JW; Lee MS; Cho BH; Park YM; Kim W; Choi JE; Jung IK; Kim L; Lee MS
Hum Psychopharmacol; 2007 Dec; 22(8):501-4. PubMed ID: 17726725
[TBL] [Abstract][Full Text] [Related]
20. Association study of tardive dyskinesia and five DRD4 polymorphisms in schizophrenia patients.
Zai CC; Tiwari AK; Basile V; De Luca V; Müller DJ; King N; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Pharmacogenomics J; 2009 Jun; 9(3):168-74. PubMed ID: 19238168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]